<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18307">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01893710</url>
  </required_header>
  <id_info>
    <org_study_id>Pediatric PD Biopsy Study</org_study_id>
    <secondary_id>University of Heidelberg</secondary_id>
    <nct_id>NCT01893710</nct_id>
  </id_info>
  <brief_title>International Pediatric Peritoneal Biopsy Study</brief_title>
  <official_title>International Pediatric Peritoneal Biopsy Study in Children on PD and Healthy Controls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients
      undergoes substantial morphological transformation, including progressive fibrosis,
      vasculopathy and neoangiogenesis. Ultrafiltration capacity steadily declines and ultimately
      results in PD failure. In children, peritoneal biopsies demonstrating PD associated
      alterations have not yet been obtained. They, however, should be particularly informative,
      since secondary tissue and vascular pathology related to ageing or diabetes is absent.

      An international, prospective peritoneal membrane biopsy study in children on PD will
      therefore be performed. Biopsies will be obtained at time of PD catheter insertion, on
      occasion of intercurrent abdominal surgery (e.g. hernia repair, catheter exchange) and at
      time of renal transplantation. Quantitative histomorphometry and tissue protein expression
      analyses will be correlated with time integrated PD treatment modalities and functional
      characteristics as well as inflammatory and cardiovascular comorbidity surrogate parameter.
      Blood will be obtained during clinical routine sampling. Biopsies will be obtained during
      clinically indicated operations, without substantially increasing operation time and
      associated surgical risks. The detailed histomorphometry of the PD membrane will give
      additional information, potentially impacting on the individual PD regime.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Please see study protocol and

      http://www.pedpd.org

      http://4c-study.org
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Semiquantitiave score of peritoneal vasculopathy (grade 0-5)</measure>
    <time_frame>Two years (Mean PD treatment time)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Children requiring peritoneal dialysis will undergo repeated biopsy sampling, i.e. at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation, according to a standardized biopsy protocol. All samples will be transferred to the pediatric nephrology laboratory Heidelberg for central analyses.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of vessels per peritoneal membrane area (per mm²)</measure>
    <time_frame>at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quantitative histomorphometry will assess neoangiogenesis, i.e. the number of vessels per peritoneal membrane area, the major factor of peritoneal transport property and ultrafiltration capacity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Submesothelial thickness (µm)</measure>
    <time_frame>2 years (average PD duration)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Further parameter of interst is submesothelial thickness as a marker of peritoneal fibrosis.</description>
  </other_outcome>
  <other_outcome>
    <measure>Leucocyte number (/mm²)</measure>
    <time_frame>2 years (mean PD duration)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Leucocyte infiltration is a parameter of PD induced membrane inflammation.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Chronic Renal Failure</condition>
  <arm_group>
    <arm_group_label>Control, PD</arm_group_label>
    <description>Peritoneal biopsies from children without kidney disease, i.e. diseases not related to the kidney and not affecting the peritoneum, will be compared with biopsies from patients with chronic kidney disease, at time of catheter insertion, intercurrent abdominal surgery and at time of renal transplantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biopsy sampling</intervention_name>
    <description>Two parietal peritoneal samples, each 1 cm² x 0.3 cm in depth and three omental tissue samples, each 1 cm² in size will be obtained.</description>
    <arm_group_label>Control, PD</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Parietal ond omental peritoneal membrane specimen will be collected
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        See below eligibility data
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 0 to 21 years

          -  CKD 5d, peritoneal dialysis and

          -  Patients with normal renal function and elective abdominal surgery due to limited
             pathology not affecting the peritoneum

          -  Oral and written consent

        Exclusion Criteria:

          -  Contraindications to peritoneal dialysis, such as severe abdominal adhesions,
             malformations and inflammations

          -  Pregnancy

          -  Preterm babies (below 37 weeks of gestational age)

          -  If serum hemoglobin &lt; 8 g/dl in children and  &lt; 10 g/dl in newborns
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claus P Schmitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Heidelberg, Center for Pediatric and Adolescent Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claus P Schmitt, MD</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>39313</phone_ext>
    <email>claus.peter.schmitt@med.uni-heidelberg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley A. Warady, MD</last_name>
      <phone>816-234-3010</phone>
      <email>bwarady@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley A. Warady, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children´s Hospital of Philadelphia</name>
      <address>
        <city>Narberth</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Arbeiter, MD</last_name>
      <phone>+43 1404003257</phone>
      <email>klaus.arbeiter@meduniwien.ac.at</email>
    </contact>
    <investigator>
      <last_name>Klaus Arbeiter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9890</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Prague</city>
        <zip>15006</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de pédiatrie 2, Hôpital saint Jacques</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital des Enfants</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Service de Néphrologie Pédiatrique, Hôpital Femme Mere Enfant</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Ranchin, MD</last_name>
      <phone>+33 427856129</phone>
      <email>bruno.ranchin@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno Ranchin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Fischbach, MD</last_name>
      <phone>+33 3127743</phone>
      <email>Michel.Fischbach@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Michel Fischbach, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Querfeld, MD</last_name>
      <phone>+49 30450516031</phone>
      <email>uwe.querfeld@charite.de</email>
    </contact>
    <investigator>
      <last_name>Uwe Querfeld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Cologne</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Taylan, MD</last_name>
      <phone>+49 2214784391</phone>
      <email>christina.taylan@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Christina Taylan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UKE, University Children´s Hospital</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Sallay, MD</last_name>
      <phone>+36 13343186</phone>
      <email>sallay.peter@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Peter Sallay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`Hospital</name>
      <address>
        <city>Genova</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Verrina, MD</last_name>
      <phone>+39 3475704081</phone>
      <email>enricoverrina@ospedale-gaslini.ge.it</email>
    </contact>
    <investigator>
      <last_name>Enrico Verrina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Testa, MD</last_name>
      <phone>+39 0257992471</phone>
      <email>saratesta@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Sara Testa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric Nephrology, Dialysis and Transplant Unit</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Vidal, MD</last_name>
      <phone>+39 0498213596</phone>
      <email>enrico.vidal@inwind.it</email>
    </contact>
    <investigator>
      <last_name>Enrico Vidal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rafik Hariri University Hospital</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University children`s Hospital</name>
      <address>
        <city>Vilnius</city>
        <zip>08406</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Paediatric CAPD unit, Kuala Lumpur Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Materno-Infantil Vall d' Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gema Ariceta, MD</last_name>
      <phone>+34 934893082</phone>
      <email>gariceta@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Gema Ariceta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael T Krmar, MD, PhD</last_name>
      <phone>+46 858581480</phone>
      <email>Rafael.Krmar@ki.se</email>
    </contact>
    <investigator>
      <last_name>Rafael T Krmar, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Inselspital, Bern University Hospital and University of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Children`s Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aysun K Bayazit, MD</last_name>
      <phone>+90 3223386935</phone>
      <email>ayskar@cu.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Aysun K Bayazit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cerrahpasa School of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34303</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salim Caliskan, MD</last_name>
      <phone>+90 5322121302</phone>
      <email>salimc@istanbul.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Salim Caliskan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Lebanon</country>
    <country>Lithuania</country>
    <country>Malaysia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://4c-study.org</url>
    <description>Cardiovascular Comorbidity in Children with Chronic Kidney Disease</description>
  </link>
  <link>
    <url>http://www.pedpd.org</url>
    <description>International Pediatric Peritoneal Dialysis Network</description>
  </link>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 2, 2013</lastchanged_date>
  <firstreceived_date>June 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Heidelberg</investigator_affiliation>
    <investigator_full_name>Claus Peter Schmitt</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>peritoneal dialysis</keyword>
  <keyword>parietal peritoneum</keyword>
  <keyword>omentum</keyword>
  <keyword>children</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
